FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion

Title
FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion
Authors
Keywords
Bosentan, Pediatric, Pulmonary arterial hypertension, Safety
Journal
INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 202, Issue -, Pages 52-58
Publisher
Elsevier BV
Online
2015-08-09
DOI
10.1016/j.ijcard.2015.08.080

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started